Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

By sjmartinez • January 29, 2025

Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA. Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093/cid/ciae648. Epub ahead of print. PMID: 39873495.

Tags: antiretroviral agents, Cabotegravir, Health policy, Infectious Diseases, lenacapavir, Pre-exposure prophylaxis, Publications

Prevalence, characteristics, and clinical course of mpox-related ophthalmic disease (MBOTE-EYE): a prospective cohort study in South Kivu, Democratic Republic of the Congo

Kabesha T, Van Dijck C, Mudwanga S, Houben S, Mujula Y, Munganga P, Tshomba JC, Mukari G, Wawina-Bokalanga T, Kinganda-Lusamaki E, Jacobs BK, Tsoumanis A,[...]

Determinants of PrEP Delivery Platform Choice in Adolescents and Young People: The Fast-PrEP Project in Cape Town, South Africa

Rousseau E, Bondarchuk C, Lebelo K, Matsebula L, Bennin F, Macdonald P, Pike C, Vanto O, Mathole N, Fynn L, Davey DJ, Coakley C, Wallace[...]

Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis From Uganda

Ross JE, Tomoiaga AS, Owor N, Lu X, Shinyale J, Kiyingi T, Asasira I, Eliku PJ, Nsubuga JB, Nsereko C, Nayiga I, Kyebambe S, Ochar[...]